AAHP Mourns the Loss of Dr. Peter Fisher

AAHP, along with the global homeopathic community, is shocked and saddened to learn of the tragic and untimely death of Dr. Peter Fisher. A champion of homeopathic medicine, Peter was the director of Research at the Royal London Hospital for Integrated Medicine, Europe’s largest center for integrative medicine. He was readm more…

Read More

Staff Can Amplify Your Message on Social Media

Your employees might not all be marketers, but with the rise of social media, they can all be advocates for your company and homeopathy in general.   Given that people are active on social media for an average of two hours a day, it’s a missed opportunity if your employees readm more…

Read More

The British Homœopathic Pharmacopœia

By Eric Foxman, AAHP Secretary A quick look at its history, purpose, and contents, as well as the potential for adulteration and misbranding violations in the U.S. market. readm more…

Read More

Prepare for Recalls: 5 Crucial Steps

By Ryan Gooley, Recall Consultant, Stericycle   Recalls impact thousands of companies every year, and they represent serious risk for the brands impacted. Homeopathic recalls, especially those involving products meant for children or the elderly, can cause widespread media coverage and consumer panic, potentially flooding call center phone lines and readm more…

Read More

Homeopathic Industry Mourns John A. Borneman, III

MILWAUKIE, Ore., July 13, 2018 — The American Association of Homeopathic Pharmacists (AAHP) mourns the loss of an industry legend. John A. (Jack) Borneman, III, grandson of one of the founding members of AAHP, passed away on July 9, 2018. Among the many industry leadership positions he held, Borneman was readm more…

Read More

Basic Science Research on Homeopathy

By Iris R. Bell, MD PhD, Professor Emeritus, The University of Arizona, Consultant, Standard Homeopathic/Hyland’s Inc. July 2, 2018 Overview Recent basic science research on homeopathy has expanded understanding of the nature of remedies and their potential biological effects. This paper provides (a) a brief overview of key data and readm more…

Read More

Health Care Product Recalls

By Mark Land, AAHP President July 1, 2018 Product recalls are an important tool for manufacturers and the Food and Drug Administration (FDA) to minimize exposure to potentially harmful or ineffective products. Drug product recalls are voluntary — that is to say FDA does not have legal authority to recall readm more…

Read More

Crystal Ball: 2018 Federal Election

By Pete Evich, AAHP government relations “It’s tough to make predictions, especially about the future.” ― Yogi Berra With the mid-term federal elections almost five months down the road, it’s high-season for those of us in the business of Congress-watching to prognosticate what is likely to transpire this November. Five readm more…

Read More

Calendula officinalis: A Clinical Snapshot

By Todd Hoover, MD July 1, 2018 Calendula officinalis has a long-standing history of traditional herbal use for skin irritations and infections. A tincture of the flowering tops of the common marigold is used to prepare the homeopathic products of this plant. Traditional homeopathic uses for Calendula officinalis often focused readm more…

Read More

Homeopathic Manufacturers Campaign Sends 38,000 Letters to Capitol Hill

MILWAUKIE, Ore., June 27, 2018 — As the result of the American Association of Homeopathic Pharmacists’ (AAHP) first grassroots effort, 38,000 letters from consumers and health care providers poured into offices of U.S. senators and representatives this spring. The letter-writing campaign urged Congressional leaders to ask the U.S. Food and readm more…

Read More